避妊薬市場：製品、性別、方法、流通別-2025-2030年の世界予測

避妊薬市場の2023年の市場規模は484億3,000万米ドルで、2024年には548億7,000万米ドルに達すると予測され、CAGR 13.82％で成長し、2030年には1,198億9,000万米ドルに達すると予測されています。

避妊薬市場には、妊娠の予防、リプロダクティブ・ヘルス（生殖に関する健康）の管理、性感染症への対処を目的としたさまざまな製品とサービスが含まれます。その範囲には、ピルや注射式避妊薬などのホルモン法、コンドームやダイアフラムなどのバリア法、子宮内避妊器具（IUD）、避妊薬インプラントやパッチなどの新技術が含まれます。このような製品の必要性は、リプロダクティブ・ヘルス（性と生殖に関する健康）の権利、人口抑制、家族計画に関して十分な情報を得た上で選択する女性のエンパワーメントに対する世界の関心の高まりに後押しされています。避妊薬の用途は幅広く、一時的なニーズにも長期的なニーズにも対応しており、最終用途の範囲は個人消費者からヘルスケアプロバイダーや組織的な流通チャネルにまで及んでいます。

避妊薬市場に影響を与える主な成長要因には、リプロダクティブ・ヘルス対策に対する認識と受容の高まり、家族計画に対する政府の支援キャンペーン、より効率的で便利な避妊薬法につながる技術の進歩などがあります。避妊に対するアンメットニーズが高い発展途上地域でのアクセス拡大や、より個別化された副作用のない選択肢を求める先進国の需要への対応には、潜在的なビジネスチャンスがあります。政府や非政府組織との戦略的パートナーシップは、市場へのリーチと浸透を強化することができます。しかし、社会的・宗教的抵抗、副作用の可能性、使用に関する誤解、各地域における規制上の課題などから、市場成長は限界に直面しています。

研究が熟している革新的な分野には、男性用避妊薬の開発、女性の副作用を軽減する非ホルモン性オプション、個人に合わせた避妊薬アドバイスを提供するデジタルヘルスソリューションなどがあります。避妊薬市場はダイナミックで、文化的、社会的、経済的要因に非常に敏感です。市場行動に関する洞察によれば、消費者の嗜好は利便性、最小限の侵襲性、長期的な信頼性へとシフトしており、これらのイノベーションに投資する企業にとって大きな可能性を示しています。戦略的提言としては、最先端ソリューションの研究開発への投資、消費者教育の強化、文化的障壁や誤解を克服するためのマーケティング戦略の調整などが挙げられます。

市場力学：急速に進化する避妊薬市場における主要市場インサイトの解明

避妊薬市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 性の健康と家族計画に関する意識の高まり
  • 避妊薬ピルの使用と提供を奨励する政府の支援イニシアティブ
• 市場抑制要因
  • 避妊薬製品による健康への悪影響
• 市場機会
  • 広範な研究開発による手頃な価格の避妊薬法のイントロダクション
  • オンライン流通チャネルを通じた避妊薬の入手可能性
• 市場の課題
  • 避妊薬使用に関する社会的懸念と製品マーケティングの問題

ポーターの5つの力：避妊薬市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、避妊薬市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：避妊薬市場における外部からの影響の把握

外部マクロ環境要因は、避妊薬市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析避妊薬市場における競合情勢の把握

避妊薬市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス避妊薬市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、避妊薬市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限はベンダーを明確かつ正確に区分し、ユーザーが戦略目標に最適なパートナーやソリューションを特定するのに役立ちます。

本レポートは、主要な注目分野を網羅した包括的な市場分析を提供しています：

1.市場の浸透度：業界主要企業の広範なデータを含む、現在の市場環境の詳細なレビュー。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 性的な健康と家族計画に関する意識の向上
    • 避妊薬ピルの使用と提供を奨励するための政府の支援策
  • 抑制要因
    • 避妊薬製品による健康への悪影響
  • 機会
    • 広範囲な研究開発による手頃な価格の避妊薬方式のイントロダクション
    • オンライン流通チャネルを通じた避妊具の入手可能性
  • 課題
    • 避妊薬の使用に関する社会的懸念と製品マーケティングの問題
• 市場セグメンテーション分析
  • 製品：使いやすさと非侵襲性のため、避妊薬薬剤に対する高い傾向
  • 性別：幅広い製品が利用できるため、女性用避妊具の採用が大幅に増加している
  • 方法：性行為中に物理的および化学的バリアを提供するバリア避妊法の好感度が高まっている
  • 流通チャネル：オンライン薬局の24時間365日のサービスにより、製品の流通が強化されます。
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 避妊薬市場：製品別

• デバイス
  • コンドーム
  • ダイヤフラム
  • 子宮内避妊器具
    • 銅製IUD
    • ホルモン性IUD
  • 皮下インプラント
  • 膣リング
• 薬物
  • 注射剤
  • 経口避妊薬錠剤
  • 経皮避妊薬パッチ

第7章 避妊薬市場性別

• 女性避妊薬
• 男性避妊薬

第8章 避妊薬市場：方法別

• バリア
• ハーモナル

第9章 避妊薬市場配布元

• チェーン薬局
• クリニック
• 政府ネットワーク
• 病院薬局
• 独立薬局
• オンラインプラットフォーム

第10章 南北アメリカの避妊薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の避妊薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの避妊薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • リッチモンドバイオテクノロジー社が避妊薬事業を1億米ドルで買収へ
  • 英国、ホルモンフリーの男性用避妊薬の初の試験を開始
  • AditxtがPhexxi避妊薬ゲルメーカーEvofemを1億米ドルで買収
  • デア・バイオサイエンスがホルモンフリーの第3相避妊薬試験を開始
  • ルピン社、米国でターコズ（ノルゲストレルとエチニルエストラジオール）錠USPを発売
  • バイエルとクロスベイ・メディカル、新しい子宮内システム挿入器を開発
  • Xiromed LLC、米国でEnilloRingの発売を発表
  • バイエル、現代的避妊法の世界の普及促進に向け、フィンランドに2億6,720万米ドルの新生産施設を建設へ
  • NIHセンター助成金が男性調査を強化
  • ゲイツ財団、チルドレンズ・インベストメント・ファンド財団、ファイザー、BD社が女性のための注射剤へのアクセス拡大に向けて提携を拡大
  • ペリゴ、米国FDAがOTCデイリーオーラル薬「オピル」の承認を発表避妊薬
  • FDAが初の処方箋不要の経口薬を承認避妊薬
  • シロナ、インド初のビーガンコンドームブランド「ブルー」を買収

企業一覧

• Abbvie Inc.
• Acme Generics Pvt. Ltd.
• Afaxys, Inc.
• Agile Therapeutics, Inc.
• Amneal Pharmaceuticals LLC
• ASKA Pharmaceutical Co., Ltd.
• Aurobindo Pharma Limited
• Bayer AG
• Church & Dwight Co., Inc.
• HLL Lifecare Limited
• Insud Pharma, S.L.
• Johnson & Johnson Services, Inc.
• Lupin Limited
• Mayne Pharma Group Limited
• Merck & Co., Inc.
• Mithra Pharmaceuticals S.A.
• Okamoto Industries, Inc.
• Organon & Co.
• Perrigo Company plc
• Pfizer Inc.
• Piramal Pharma Ltd.
• Reckitt Benckiser Group plc
• RITEX GMBH
• Sanofi S.A.
• Say It With A Condom, LLC.
• Syzygy Healthcare Solutions LLC
• Teva Pharmaceutical Industries Ltd.
• TherapeuticsMD, Inc.
• TTK Healthcare Limited
• Veru Inc.
• Viatris Inc.

LIST OF FIGURES

• FIGURE 1. CONTRACEPTIVE MARKET RESEARCH PROCESS
• FIGURE 2. CONTRACEPTIVE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CONTRACEPTIVE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CONTRACEPTIVE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CONTRACEPTIVE MARKET SIZE, BY GENDER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CONTRACEPTIVE MARKET SIZE, BY GENDER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CONTRACEPTIVE MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL CONTRACEPTIVE MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. CONTRACEPTIVE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. CONTRACEPTIVE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CONTRACEPTIVE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CONTRACEPTIVE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CONTRACEPTIVE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CONTRACEPTIVE MARKET DYNAMICS
• TABLE 7. GLOBAL CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CONTRACEPTIVE MARKET SIZE, BY CONDOMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DIAPHRAGM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CONTRACEPTIVE MARKET SIZE, BY IUDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CONTRACEPTIVE MARKET SIZE, BY COPPER IUDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CONTRACEPTIVE MARKET SIZE, BY HORMONAL IUDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CONTRACEPTIVE MARKET SIZE, BY SUBDERMAL IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CONTRACEPTIVE MARKET SIZE, BY VAGINAL RINGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL CONTRACEPTIVE MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL CONTRACEPTIVE MARKET SIZE, BY ORAL CONTRACEPTIVE PILLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL CONTRACEPTIVE MARKET SIZE, BY TRANSDERMAL CONTRACEPTIVE PATCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL CONTRACEPTIVE MARKET SIZE, BY FEMALE CONTRACEPTIVE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL CONTRACEPTIVE MARKET SIZE, BY MALE CONTRACEPTIVE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL CONTRACEPTIVE MARKET SIZE, BY BARRIER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL CONTRACEPTIVE MARKET SIZE, BY HARMONAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL CONTRACEPTIVE MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL CONTRACEPTIVE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL CONTRACEPTIVE MARKET SIZE, BY GOVERNMENT NETWORK, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL CONTRACEPTIVE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL CONTRACEPTIVE MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL CONTRACEPTIVE MARKET SIZE, BY ONLINE PLATFORM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 43. AMERICAS CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
• TABLE 47. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 48. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 49. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 50. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 53. BRAZIL CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
• TABLE 54. BRAZIL CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 55. BRAZIL CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 56. BRAZIL CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 57. BRAZIL CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 58. CANADA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. CANADA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 60. CANADA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
• TABLE 61. CANADA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 62. CANADA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 63. CANADA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 64. CANADA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 65. MEXICO CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. MEXICO CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 67. MEXICO CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
• TABLE 68. MEXICO CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 69. MEXICO CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 70. MEXICO CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 71. MEXICO CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 72. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 74. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
• TABLE 75. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 76. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 77. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 78. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 79. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 80. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 82. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
• TABLE 83. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 84. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 85. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 86. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 87. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 88. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 90. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
• TABLE 91. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 92. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 93. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 94. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 95. CHINA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. CHINA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 97. CHINA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
• TABLE 98. CHINA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 99. CHINA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 100. CHINA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 101. CHINA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 102. INDIA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. INDIA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 104. INDIA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
• TABLE 105. INDIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 106. INDIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 107. INDIA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 108. INDIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 109. INDONESIA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 110. INDONESIA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 111. INDONESIA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
• TABLE 112. INDONESIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 113. INDONESIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 114. INDONESIA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 115. INDONESIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 116. JAPAN CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 117. JAPAN CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 118. JAPAN CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
• TABLE 119. JAPAN CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 120. JAPAN CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 121. JAPAN CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 122. JAPAN CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 123. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 124. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 125. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
• TABLE 126. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 127. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 128. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 129. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 130. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 131. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 132. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
• TABLE 133. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 134. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 135. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 136. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 137. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 139. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
• TABLE 140. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 141. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 142. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 143. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 144. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 145. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 146. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
• TABLE 147. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 148. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 149. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 150. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 151. TAIWAN CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 152. TAIWAN CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 153. TAIWAN CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
• TABLE 154. TAIWAN CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 155. TAIWAN CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 156. TAIWAN CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 157. TAIWAN CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 158. THAILAND CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 159. THAILAND CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 160. THAILAND CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
• TABLE 161. THAILAND CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 162. THAILAND CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 163. THAILAND CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 164. THAILAND CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 165. VIETNAM CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 166. VIETNAM CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 167. VIETNAM CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
• TABLE 168. VIETNAM CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 169. VIETNAM CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 170. VIETNAM CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 171. VIETNAM CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 172. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 173. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 174. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
• TABLE 175. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 176. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 177. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 178. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 179. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 180. DENMARK CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 181. DENMARK CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 182. DENMARK CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
• TABLE 183. DENMARK CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 184. DENMARK CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 185. DENMARK CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 186. DENMARK CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 187. EGYPT CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 188. EGYPT CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 189. EGYPT CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
• TABLE 190. EGYPT CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 191. EGYPT CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 192. EGYPT CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 193. EGYPT CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 194. FINLAND CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 195. FINLAND CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 196. FINLAND CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
• TABLE 197. FINLAND CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 198. FINLAND CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 199. FINLAND CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 200. FINLAND CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 201. FRANCE CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 202. FRANCE CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 203. FRANCE CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
• TABLE 204. FRANCE CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 205. FRANCE CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 206. FRANCE CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 207. FRANCE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 208. GERMANY CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 209. GERMANY CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 210. GERMANY CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
• TABLE 211. GERMANY CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 212. GERMANY CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 213. GERMANY CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 214. GERMANY CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 215. ISRAEL CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 216. ISRAEL CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 217. ISRAEL CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
• TABLE 218. ISRAEL CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 219. ISRAEL CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 220. ISRAEL CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 221. ISRAEL CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 222. ITALY CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 223. ITALY CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 224. ITALY CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
• TABLE 225. ITALY CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 226. ITALY CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 227. ITALY CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 228. ITALY CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 229. NETHERLANDS CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 230. NETHERLANDS CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 231. NETHERLANDS CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
• TABLE 232. NETHERLANDS CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 233. NETHERLANDS CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 234. NETHERLANDS CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 235. NETHERLANDS CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 236. NIGERIA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 237. NIGERIA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 238. NIGERIA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
• TABLE 239. NIGERIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 240. NIGERIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 241. NIGERIA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 242. NIGERIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 243. NORWAY CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 244. NORWAY CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 245. NORWAY CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
• TABLE 246. NORWAY CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 247. NORWAY CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 248. NORWAY CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 249. NORWAY CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 250. POLAND CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 251. POLAND CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 252. POLAND CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
• TABLE 253. POLAND CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 254. POLAND CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 255. POLAND CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 256. POLAND CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 257. QATAR CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 258. QATAR CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 259. QATAR CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
• TABLE 260. QATAR CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 261. QATAR CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 262. QATAR CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 263. QATAR CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 264. RUSSIA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 265. RUSSIA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 266. RUSSIA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
• TABLE 267. RUSSIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 268. RUSSIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 269. RUSSIA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 270. RUSSIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 271. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 272. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 273. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
• TABLE 274. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 275. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 276. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 277. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 278. SOUTH AFRICA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 279. SOUTH AFRICA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 280. SOUTH AFRICA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
• TABLE 281. SOUTH AFRICA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 282. SOUTH AFRICA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 283. SOUTH AFRICA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 284. SOUTH AFRICA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 285. SPAIN CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 286. SPAIN CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 287. SPAIN CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
• TABLE 288. SPAIN CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 289. SPAIN CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 290. SPAIN CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 291. SPAIN CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 292. SWEDEN CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 293. SWEDEN CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 294. SWEDEN CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
• TABLE 295. SWEDEN CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 296. SWEDEN CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 297. SWEDEN CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 298. SWEDEN CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 299. SWITZERLAND CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 300. SWITZERLAND CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 301. SWITZERLAND CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
• TABLE 302. SWITZERLAND CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 303. SWITZERLAND CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 304. SWITZERLAND CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 305. SWITZERLAND CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 306. TURKEY CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 307. TURKEY CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 308. TURKEY CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
• TABLE 309. TURKEY CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 310. TURKEY CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 311. TURKEY CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 312. TURKEY CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 313. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 314. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 315. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
• TABLE 316. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 317. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 318. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 319. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 320. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 321. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 322. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
• TABLE 323. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 324. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 325. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 326. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 327. CONTRACEPTIVE MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 328. CONTRACEPTIVE MARKET, FPNV POSITIONING MATRIX, 2023

The Contraceptive Market was valued at USD 48.43 billion in 2023, expected to reach USD 54.87 billion in 2024, and is projected to grow at a CAGR of 13.82%, to USD 119.89 billion by 2030.

The contraceptive market encompasses a range of products and services aimed at preventing pregnancy, managing reproductive health, and addressing sexually transmitted infections. Its scope includes hormonal methods like pills and injectable contraceptives, barrier methods such as condoms and diaphragms, intrauterine devices (IUDs), and emerging technologies like contraceptive implants and patches. The necessity for such products is driven by the increasing global focus on reproductive health rights, population control, and the empowerment of women to make informed choices regarding family planning. The application of contraceptives is widespread, catering to both temporary and long-term needs of users, with end-use scopes stretching from individual consumers to healthcare providers and institutional distribution channels.

Key growth factors influencing the contraceptive market include the rising awareness and acceptance of reproductive health measures, supportive governmental campaigns for family planning, and technological advancements leading to more efficient and convenient contraceptive methods. There are potential opportunities in expanding access in developing regions where unmet needs for contraceptives are high, as well as addressing the demand in developed countries for more personalized and side-effect-free options. Strategic partnerships with governmental and non-governmental organizations can enhance market reach and penetration. However, market growth faces limitations from societal and religious resistances, potential side effects and misconceptions about contraceptive use, and regulatory challenges in different regions.

Innovative areas ripe for research include the development of male contraceptives, non-hormonal options that reduce side effects for women, and digital health solutions that offer personalized contraceptive advice. The contraceptive market is dynamic and highly sensitive to cultural, social, and economic factors. Insights into market behavior suggest a consumer preference shift towards convenience, minimal invasiveness, and long-term reliability, indicating significant potential for companies investing in these innovations. Strategic recommendations include investing in R&D for cutting-edge solutions, enhancing consumer education, and tailoring marketing strategies to overcome cultural barriers and misconceptions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Contraceptive Market

The Contraceptive Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increased awareness regarding sexual health and family planning
  • Supportive government initiatives to encourage use and provision of contraceptive pills
• Market Restraints
  • Adverse health impacts of contraceptive products
• Market Opportunities
  • Introduction of affordable contraceptive methods with extensive R&D
  • Availability of contraceptives through online distribution channels
• Market Challenges
  • Social concerns regarding contraceptive usage and issues with product marketing

Porter's Five Forces: A Strategic Tool for Navigating the Contraceptive Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Contraceptive Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Contraceptive Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Contraceptive Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Contraceptive Market

A detailed market share analysis in the Contraceptive Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Contraceptive Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Contraceptive Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Contraceptive Market, highlighting leading vendors and their innovative profiles. These include Abbvie Inc., Acme Generics Pvt. Ltd., Afaxys, Inc., Agile Therapeutics, Inc., Amneal Pharmaceuticals LLC, ASKA Pharmaceutical Co., Ltd., Aurobindo Pharma Limited, Bayer AG, Church & Dwight Co., Inc., HLL Lifecare Limited, Insud Pharma, S.L., Johnson & Johnson Services, Inc., Lupin Limited, Mayne Pharma Group Limited, Merck & Co., Inc., Mithra Pharmaceuticals S.A., Okamoto Industries, Inc., Organon & Co., Perrigo Company plc, Pfizer Inc., Piramal Pharma Ltd., Reckitt Benckiser Group plc, RITEX GMBH, Sanofi S.A., Say It With A Condom, LLC., Syzygy Healthcare Solutions LLC, Teva Pharmaceutical Industries Ltd., TherapeuticsMD, Inc., TTK Healthcare Limited, Veru Inc., and Viatris Inc..

Market Segmentation & Coverage

This research report categorizes the Contraceptive Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Devices and Drugs. The Devices is further studied across Condoms, Diaphragm, IUDs, Subdermal Implants, and Vaginal Rings. The IUDs is further studied across Copper IUDs and Hormonal IUDs. The Drugs is further studied across Injectables, Oral Contraceptive Pills, and Transdermal Contraceptive Patch.
• Based on Gender, market is studied across Female Contraceptive and Male Contraceptive.
• Based on Method, market is studied across Barrier and Harmonal.
• Based on Distribution, market is studied across Chain Pharmacy, Clinics, Government Network, Hospital Pharmacy, Independent Pharmacy, and Online Platform.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increased awareness regarding sexual health and family planning
    • 5.1.1.2. Supportive government initiatives to encourage use and provision of contraceptive pills
  • 5.1.2. Restraints
    • 5.1.2.1. Adverse health impacts of contraceptive products
  • 5.1.3. Opportunities
    • 5.1.3.1. Introduction of affordable contraceptive methods with extensive R&D
    • 5.1.3.2. Availability of contraceptives through online distribution channels
  • 5.1.4. Challenges
    • 5.1.4.1. Social concerns regarding contraceptive usage and issues with product marketing
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: High inclination toward contraceptive drugs due to their ease of use and non-invasiveness
  • 5.2.2. Gender: Significant adoption of female contraceptives due to availability of a wide range of products
  • 5.2.3. Method: Rising preference for barrier methods of contraception that provide a physical and chemical barrier during sexual activities
  • 5.2.4. Distribution Channel: Enhanced product distribution through online pharmacies due to their 24/7 services
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Contraceptive Market, by Product

• 6.1. Introduction
• 6.2. Devices
  • 6.2.1. Condoms
  • 6.2.2. Diaphragm
  • 6.2.3. IUDs
    • 6.2.3.1. Copper IUDs
    • 6.2.3.2. Hormonal IUDs
  • 6.2.4. Subdermal Implants
  • 6.2.5. Vaginal Rings
• 6.3. Drugs
  • 6.3.1. Injectables
  • 6.3.2. Oral Contraceptive Pills
  • 6.3.3. Transdermal Contraceptive Patch

7. Contraceptive Market, by Gender

• 7.1. Introduction
• 7.2. Female Contraceptive
• 7.3. Male Contraceptive

8. Contraceptive Market, by Method

• 8.1. Introduction
• 8.2. Barrier
• 8.3. Harmonal

9. Contraceptive Market, by Distribution

• 9.1. Introduction
• 9.2. Chain Pharmacy
• 9.3. Clinics
• 9.4. Government Network
• 9.5. Hospital Pharmacy
• 9.6. Independent Pharmacy
• 9.7. Online Platform

10. Americas Contraceptive Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Contraceptive Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Contraceptive Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Richmond Biotech Company to buy Contraceptive biz for USD 100 Million
  • 13.3.2. UK Launches First Trial of Hormone-free Male Birth Control pill
  • 13.3.3. Aditxt Acquires Phexxi Contraceptive Gel-Maker Evofem for USD 100 million
  • 13.3.4. Dare Bioscience Launches Phase III Hormone-free Contraceptive Trial
  • 13.3.5. Lupin Launches Turqoz (Norgestrel and Ethinyl Estradiol) Tablets USP in the United States
  • 13.3.6. Bayer and CrossBay Medical to Develop Novel Intrauterine System Inserter
  • 13.3.7. Xiromed LLC Announces Launch of EnilloRing in the United States
  • 13.3.8. Bayer Invests in USD 267.2 Million new Production Facility in Finland to Accelerate Global Access to Modern Contraception
  • 13.3.9. NIH Center Grant Bolsters Male Contraceptive Research
  • 13.3.10. Gates Foundation, Children's Investment Fund Foundation, Pfizer and BD Company Expand Partnership for Greater Access to Injectable Contraceptive for Women
  • 13.3.11. Perrigo Announces U.S. FDA Approval for Opill OTC Daily Oral Contraceptive
  • 13.3.12. FDA Approves First Nonprescription Daily Oral Contraceptive
  • 13.3.13. Sirona Acquires India's First Vegan Condom Brand Bleu

Companies Mentioned

• 1. Abbvie Inc.
• 2. Acme Generics Pvt. Ltd.
• 3. Afaxys, Inc.
• 4. Agile Therapeutics, Inc.
• 5. Amneal Pharmaceuticals LLC
• 6. ASKA Pharmaceutical Co., Ltd.
• 7. Aurobindo Pharma Limited
• 8. Bayer AG
• 9. Church & Dwight Co., Inc.
• 10. HLL Lifecare Limited
• 11. Insud Pharma, S.L.
• 12. Johnson & Johnson Services, Inc.
• 13. Lupin Limited
• 14. Mayne Pharma Group Limited
• 15. Merck & Co., Inc.
• 16. Mithra Pharmaceuticals S.A.
• 17. Okamoto Industries, Inc.
• 18. Organon & Co.
• 19. Perrigo Company plc
• 20. Pfizer Inc.
• 21. Piramal Pharma Ltd.
• 22. Reckitt Benckiser Group plc
• 23. RITEX GMBH
• 24. Sanofi S.A.
• 25. Say It With A Condom, LLC.
• 26. Syzygy Healthcare Solutions LLC
• 27. Teva Pharmaceutical Industries Ltd.
• 28. TherapeuticsMD, Inc.
• 29. TTK Healthcare Limited
• 30. Veru Inc.
• 31. Viatris Inc.